NYSE American - Nasdaq Real Time Price USD
Matinas BioPharma Holdings, Inc. (MTNB)
As of 11:32 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,873.0000
-15,278.0000
-19,156.0000
-15,223.0000
-17,367.8360
Investing Cash Flow
3,106.0000
13,242.0000
4,877.0000
16,770.0000
-40,666.9520
Financing Cash Flow
9,240.0000
-7.0000
79.0000
6,965.0000
48,046.8310
End Cash Position
4,466.0000
5,037.0000
7,080.0000
21,280.0000
12,768.4810
Capital Expenditure
-886.5910
-218.0000
-892.0000
-260.0000
-5.7490
Issuance of Capital Stock
--
--
--
5,580.0000
46,704.2100
Repayment of Debt
-4.0000
-7.0000
-20.0000
-30.0000
-54.6730
Free Cash Flow
-17,889.0000
-15,496.0000
-20,048.0000
-15,483.0000
-17,373.5850
12/31/2020 - 7/21/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EQ Equillium, Inc.
0.7600
-0.72%
EPIX ESSA Pharma Inc.
1.8200
+2.82%
ELAB Elevai Labs Inc.
0.0199
+11.11%
VIRX Viracta Therapeutics, Inc.
0.1790
-1.76%
PALI Palisade Bio, Inc.
2.5300
-0.39%
MTEM Molecular Templates, Inc.
0.3666
-5.66%
PHGE BiomX Inc.
0.7598
-6.42%
CDT Conduit Pharmaceuticals Inc.
0.0952
-0.83%
ADTX Aditxt, Inc.
0.3737
+1.00%
AVTE Aerovate Therapeutics, Inc.
2.7050
-1.28%